Brief Report-Combination Capmatinib and Trametinib in Metastatic MET-driven Non-Small Cell Lung Cancer
Abstract Introduction: MET tyrosine kinase (TKI) therapy has improved outcomes in patients with non-small cell lung cancer (NSCLC) harboring MET alterations. However, primary and acquired resistance…